Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Thousands tracked for decades to see how hip implants hold up

NCT ID NCT02230826

Knowledge-focused Sponsor: Corin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 2500 people who have had hip replacement surgery with Corin implants. Researchers will check how long the implants last and how well they work over 10, 15, and 20 years. The goal is to gather safety and performance data, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,500 people

The number the study aims to enrol. It can still change while the study runs.

Start date

May 2014

Expected to finish

Dec 2044

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Cohort of patients with a partial or total hip replacement (Corin implants)

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Man or woman \>18 years * Subjects with indication of arthroplasty surgery with Corin hip devices which are under assessment as part of this PMCF study * Subjects who agreed for study participation. Exclusion Criteria: * Subjects with existing tumour and/or particularly high surgical risk- * Subjects with anaesthetic risk class IV or higher * Subjects under guardianship and/or unable to follow procedures or matters related to the study (examples: Illiterate, recent psychotic or mania disorders and / or inability to comply with usual follow-up visits.) * Contraindications for arthroplasty with a Corin hip devices as per product IFU

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Congenital dislocation of hip are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

avascular necrosis avascular necrosis of femoral head, primary, 1 developmental dysplasia of the hip familial avascular necrosis of femoral head Neoplasm Metastasis osteoarthritis osteoarthritis susceptibility 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Congenital dislocations Femur head necrosis Hip replacement Primary and revision surgery Primary, secondary or post-traumatic osteoarthrosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    6 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH Dunkerque

    TERMINATED

    Dunkirk, 59385, France

  • CHU de Bordeaux - Groupe Hospitalier Pellegrin

    ACTIVE_NOT_RECRUITING

    Bordeaux, 33000, France

  • CHU de Nice

    RECRUITING

    Nice, 06000, France

  • Centre Hospitalier Régionnal d'Orléans - Site La Source

    TERMINATED

    Orléans, 45000, France

  • Clinique Arago

    TERMINATED

    Paris, 75014, France

  • Hopital privé Saint-Martin

    ACTIVE_NOT_RECRUITING

    Pessac, 33600, France

  • Hôpital Jean Bernard

    RECRUITING

    Valenciennes, 59300, France

  • Hôpital Provo

    RECRUITING

    Roubaix, 59100, France

  • Hôpital de la Croix Saint-Simon

    RECRUITING

    Paris, 75020, France

  • Médipôle Garonne

    TERMINATED

    Toulouse, 31000, France

  • Polyclinique Henin Beaumont

    RECRUITING

    Hénin-Beaumont, 62254, France

  • Polyclinique St Georges de Didonne

    RECRUITING

    Saint-Georges-de-Didonne, 17110, France

  • clinique Oxford Cannes

    TERMINATED

    Cannes, 06400, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.